MRI scan
17 September 2021
News Category: 

The Royal Melbourne Hospital (RMH) researchers have received $17480,419 in funding from the latest round of the National Health and Medical Research Council’s (NHMRC) grant announcements this week.

The latest round of funds help studies into cancer, diabetes, mental health, palliative care, iron deficiency, Alzheimer’s disease and Aboriginal and Torres Strait Islander Health.

A major winner from the latest round of announcements is the study On TRACK (Teaching, Research And Community Knowledges), which promotes better brain health for older Aboriginal and Torres Strait Islander Peoples.The study, led by RMH Geriatrician and University of Melbourne researcher Associate Professor Dina LoGiudice, received $3,000,000 in funding.

RMH Neurologist and Walter and Eliza Hall Institute of Medical Research’s Associate Professor Nawaf Yassi was also awarded $1,280,218 to further his study into the role of the Tau protein in the development of Alzheimer’s Disease.

The RMH congratulates all NHMRC recipients.


A/Pr Simon Rice - Pragmatic trial of a targeted digital intervention for youth with suicidal thoughts and behaviours attending outpatient care

A/Pr Dina LoGiudice - On TRACK (Teaching, Research And Community Knowledges) : CRE promoting brain health with older Aboriginal and Torres Strait Islander peoples.

Prof Wen Lim - IMPART - IMproving PAlliative care in Residential aged care using Telehealth

Dr Sarah Price - Improving maternal metabolic health prior to pregnancy to prevent metabolic disease in the offspring

A/Prof Daniel Steinfort - Improving survival in lung cancer using novel minimally invasive bronchoscopic techniques

A/Prof Jo Robinson - Using social media to reduce suicide and self-harm in young people

A/Prof Sant-Rayn Pasricha- Alleviating anaemia in mothers and babies worldwide

Prof Clare Scott - Super-Responders and Super-Survivors – how to dramatically improve cancer outcomes

A/Prof Nawaf Yassi - Tau - A diagnostic and therapeutic target in Alzheimer's Disease

A/Pr John Wentworth - Combination immune therapy for type 1 diabetes